Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in 'off-the-shelf' cell therapies for solid tumours and blood cancers. The two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback